Brian Tomlinson
Department of Medicine and Therapeutics
Prince of Wales Hospital
Shatin
Hong Kong SAR; e-mail:
Name/email consistency: high
- Comments on "CYP3AP1*3 Allele Is Associated With Lipid-Lowering Efficacy of Simvastatin and Atorvastatin in Chinese Women". Hu, M., Mak, V.W., Tomlinson, B. J. Clin. Pharmacol (2012)
- ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. Tomlinson, B., Hu, M., Lee, V.W., Lui, S.S., Chu, T.T., Poon, E.W., Ko, G.T., Baum, L., Tam, L.S., Li, E.K. Clin. Pharmacol. Ther. (2010)
- In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach?. Tomlinson, B., Hu, M., Lee, V.W. Mol. Nutr. Food. Res (2008)
- Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor. Tomlinson, B. Curr. Opin. Investig. Drugs (2006)
- Febuxostat (Teijin/Ipsen/TAP). Tomlinson, B. Curr. Opin. Investig. Drugs (2005)
- Randomized, controlled, parallel-group comparison of ambulatory and clinic blood pressure responses to amlodipine or enalapril during and after treatment in adult chinese patients with hypertension. Tomlinson, B., Woo, J., Thomas, G.N., Chau, Y.M., Critchley, J.A. Clin. Ther (2004)
- SARS: experience at Prince of Wales Hospital, Hong Kong. Tomlinson, B., Cockram, C. Lancet (2003)
- How well tolerated are lipid-lowering drugs?. Tomlinson, B., Chan, P., Lan, W. Drugs. Aging (2001)
- New insights into the treatment of hypertension. Tomlinson, B. Clin. Exp. Pharmacol. Physiol. (1997)